Businesses can apply for a share of up to £1.5 million to support real-world testing of new medical devices, diagnostics and technologies in the NHS.
Innovate UK and the Office for Life Sciences are working in partnership to invest up to £1.5 million in business projects that support the development of new medical devices, diagnostics and regulated digital technology.
Most companies in the sector are small and often find it difficult to provide enough real-world evidence to support use of their innovations in the NHS. The funding will help businesses to collect that evidence. Funding will support either the development or design of plans for collection of data on clinical performance and cost effectiveness or studies that actually collect the data.
It is aimed at small and medium-sized companies that have developed and manufactured innovative healthtech, have gained a CE marking for it and have marketed it in the UK for less than 5 years.
Projects should address NHS priorities, projects should show how they are working with appropriate organisations such as the NHS and the National Institute for Health and Care Excellence. They should aim to have a significant impact and address NHS priorities including:
– reducing cancellations or unnecessary appointments
– reducing the burden on accident and emergency
– improving patient safety
– speeding up diagnosis
– enabling earlier diagnosis of cancer
– supporting management of long-term conditions such as diabetes, chronic pain management, cardiovascular disease, asthma and chronic obstructive pulmonary disease
The deadline for applications is at midday on 30 January 2019.
To find out more and for further details on applying, please click here.